214 related articles for article (PubMed ID: 20882676)
1. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database.
Manack A; Motsko SP; Haag-Molkenteller C; Dmochowski RR; Goehring EL; Nguyen-Khoa BA; Jones JK
Neurourol Urodyn; 2011 Mar; 30(3):395-401. PubMed ID: 20882676
[TBL] [Abstract][Full Text] [Related]
2. Private health insurance and medical care utilization: evidence from the Medicare population.
McCall N; Rice T; Boismier J; West R
Inquiry; 1991; 28(3):276-87. PubMed ID: 1833338
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
4. The health care status of the diabetic population as reflected by physician claims to a major insurer.
Rendell M; Kimmel DB; Bamisedun O; O'Donnell ET; Fulmer J
Arch Intern Med; 1993 Jun; 153(11):1360-6. PubMed ID: 8507126
[TBL] [Abstract][Full Text] [Related]
5. The American health care system. Health insurance coverage.
Kuttner R
N Engl J Med; 1999 Jan; 340(2):163-8. PubMed ID: 9887170
[No Abstract] [Full Text] [Related]
6. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
7. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
8. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
Finkelstein A
J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
[TBL] [Abstract][Full Text] [Related]
9. Socioeconomic status and utilization of health care services in Canada and the United States: findings from a binational health survey.
Blackwell DL; Martinez ME; Gentleman JF; Sanmartin C; Berthelot JM
Med Care; 2009 Nov; 47(11):1136-46. PubMed ID: 19786920
[TBL] [Abstract][Full Text] [Related]
10. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
Raebel MA; Delate T; Ellis JL; Bayliss EA
Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
[TBL] [Abstract][Full Text] [Related]
11. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
12. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
[TBL] [Abstract][Full Text] [Related]
14. Medical visits among adults with symptoms commonly associated with an overactive bladder.
Kim SH; Boye M; Bhattacharyya SK; Coyne K; Dhawan R
BJU Int; 2006 Mar; 97(3):551-4. PubMed ID: 16469024
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in predictors of late-life health insurance knowledge.
Jacobs-Lawson JM; Schumacher MM; Webb A
J Women Aging; 2007; 19(3-4):121-36. PubMed ID: 18032257
[TBL] [Abstract][Full Text] [Related]
16. Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact.
Thom DH; Nygaard IE; Calhoun EA
J Urol; 2005 Apr; 173(4):1295-301. PubMed ID: 15758785
[TBL] [Abstract][Full Text] [Related]
17. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization among surgically treated Medicare beneficiaries with lung cancer.
Farjah F; Wood DE; Varghese TK; Massarweh NN; Symons RG; Flum DR
Ann Thorac Surg; 2009 Dec; 88(6):1749-56. PubMed ID: 19932230
[TBL] [Abstract][Full Text] [Related]
20. Rates of hospitalization for asthma by insurance status.
Stanford R; Okamoto L; McLaughlin T
MedGenMed; 2000 Jan; 2(1):E5. PubMed ID: 11104451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
